Champlain Investment Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Champlain Investment Partners's DXCM Position: Q2 2026 in Review
Champlain Investment Partners opened a new position in DexCom (DXCM) in Q2 2026: 269,217 shares worth $18.1M. The stake represents 0.47% of the portfolio and ranks #104 among its holdings. This is a return to the name: Champlain Investment Partners previously reported a position in DXCM as recently as Q3 2025.
Champlain Investment Partners first reported a position in DXCM in Q1 2022 and has held it in 16 quarters since. The position peaked at $285M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Champlain Investment Partners held 269,217 shares of DexCom worth $18.1M as of Q2 2026.
- DexCom was a new Champlain Investment Partners position in Q2 2026.
- DexCom made up 0.47% of Champlain Investment Partners's portfolio in Q2 2026, its #104 holding.
- Champlain Investment Partners first reported a position in DexCom in Q1 2022 and has held it in 16 quarters since.
- Champlain Investment Partners's DexCom position peaked at $285M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.